Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Alimta Pemetrexed Pr 500mg Suv Inj

Item No.: Rx00002-7623-01 Generic Name:<Br>Pemetrexed<Br> Description:<Br>Alimta Pr 500mg Suv <Br> Alt Item #: <Br>3549623<Br> NDC: <Br>00002-7623-01<Br> UPC: <Br>300027-623016<Br> Contract:<Br>Contra Generic Name:
PEMETREXED

 Description:
ALIMTA PR 500MG SUV 
 Alt Item #: 
3549623

 NDC:
00002-7623-01

 UPC:
300027-623016
 Contract:

Contract Alias:

Strength:
500MG

 Form:
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Rx Item-Alimta Pemetrexed Pr 500mg Suv Inj

$4851.60$4499.00

Item No.: Rx00002-7623-01 UPC 3-00027-62301-6 300027623016 300027-623016 Generic Name:
Pemetrexed
Description:
Alimta Pr 500mg Suv
Alt Item #:
3549623
NDC:
00002-7623-01
UPC:
300027-623016
Contract:
Contract Alias:
Strength:
500Mg
Form:
Powder Vial
Size:
1X1 Each Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, Pharmacist, PA, Physical Therapist, Podiatrist, Res

Have a question?

Clinical Information Gen. Code and Des. 53600 pemetrexed disodium INTRAVEN VIAL 500 MG GCN and Des. 21179 pemetrexed disodium INTRAVEN VIAL 500 MG Strength 500MG Dose Form VIAL (EA) Product Category RX Pharmaceuticals Fine Line Class 850085008510 All Rx Products DEA Class NC OMP Family AHFS Class 10000000 ANTINEOPLASTIC AGENTS Active Ingredients 8495 pemetrexed disodium 150399238 Inactive Ingredients 2272 mannitol 69658 These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection), for Intravenous Use Initial U.S. Approval: 2004 RECENT MAJOR CHANGES Indications and Usage (1.1) 06/2018 Dosage and Administration (2.1) 06/2018 INDICATIONS AND USAGE ALIMTA� is a folate analog metabolic inhibitor indicated: in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC). (1.1) in combination with carboplatin and pembrolizumab for the initial treatment of patients with metastatic, non-squamous NSCLC. This indication is approved under accelerated approval based on tumor response rate and progression-free survival. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials. (1.1) as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. (1.1) as a single agent for the treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy. (1.1) Limitations of Use: ALIMTA is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer. (1.1) initial treatment, in combination with cisplatin, of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery. (1.2) DOSAGE AND ADMINISTRATION The recommended dose of ALIMTA, administered as a single agent or with cisplatin or with carboplatin and pembrolizumab, in patients with creatinine clearance of 45 mL/minute or greater, is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle. (2.1, 2.2) Initiate folic acid 400 mcg to 1000 mcg orally, once daily, beginning 7 days prior to the first dose of ALIMTA and continue until 21 days after the last dose of ALIMTA. (2.4) Administer vitamin B12, 1 mg intramuscularly, 1 week prior to the first dose of ALIMTA and every 3 cycles. (2.4) Administer dexamethasone 4 mg orally, twice daily the day before, the day of, and the day after ALIMTA administration. (2.4) DOSAGE FORMS AND STRENGTHS For Injection: 100 mg or 500 mg lyophilized powder in single-dose vial. (3) CONTRAINDICATIONS History of severe hypersensitivity reaction to pemetrexed. (4) WARNINGS AND PRECAUTIONS Myelosuppression: Can cause severe bone marrow suppression resulting in cytopenia and an increased risk of infection. Do not administer ALIMTA when the absolute neutrophil count is less than 1500 cells/mm3 and platelets are less than 100,000 cells/mm3. Initiate supplementation with oral folic acid and intramuscular vitamin B12 to reduce the severity of hematologic and gastrointestinal toxicity of ALIMTA. (2.6, 5.1) Renal Failure: Can cause severe, and sometimes fatal, renal failure. Do not administer when creatinine clearance is less than 45 mL/min. (2.3, 5.2) Bullous and Exfoliative Skin Toxicity: Permanently discontinue for severe and life-threatening bullous, blistering or exfoliating skin toxicity. (5.3) Interstitial Pneumonitis: Withhold for acute onset of new or progressive unexplained pulmonary symptoms. Permanently discontinue if pneumonitis is confirmed. (5.4) Radiation Recall: Can occur in patients who received radiation weeks to years previously; permanently discontinue for signs of radiation recall. (5.5) Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of the potential risk to a fetus and to use effective contraception. (5.7, 8.1, 8.3) ADVERSE REACTIONS The most common adverse reactions (incidence ?20%) of ALIMTA, when administered as a single agent are fatigue, nausea, and anorexia. (6.1) The most common adverse reactions (incidence ?20%) of ALIMTA when administered with cisplatin are vomiting, neutropenia, anemia, stomatitis/pharyngitis, thrombocytopenia, and constipation. (6.1) The most common adverse reactions (incidence ?30%) of ALIMTA when administered in combination with carboplatin and pembrolizumab are fatigue, nausea, constipation, rash, vomiting, dyspnea, diarrhea, headache, and decreased appetite. To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS Ibuprofen increased risk of ALIMTA toxicity in patients with mild to moderate renal impairment. Modify the ibuprofen dosage as recommended for patients with a creatinine clearance between 45 mL/min and 79 mL/min. (2.5, 5.6, 7) USE IN SPECIFIC POPULATIONS Lactation: Advise not to breastfeed. (8.2) See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. Revised: 6/2018

Item No.: Rx00002-7623-01 Generic Name:<Br>Pemetrexed<Br> Description:<Br>Alimta Pr 500mg Suv <Br> Alt Item #: <Br>3549623<Br> NDC: <Br>00002-7623-01<Br> UPC: <Br>300027-623016<Br> Contract:<Br>Contra
Rx Item-Alimta Pemetrexed Pr 500mg Suv I
Item No.: Rx00002-7623-01 Generic Name:
Pemetrexed
Description:
Alimta Pr 500mg Suv
Alt Item #:
3549623
NDC:
00002-7623-01
UPC:
300027-623016
Contract:
Contra

 Generic Name:
PEMETREXED

 Description:
ALIMTA PR 500MG SUV 
 Alt Item #: 
3549623

 NDC:
00002-7623-01

 UPC:
300027-623016
 Contract:

Contract Alias:

Strength:
500MG

 Form:
LILLY
Generic Name: PEMETREXED Description: ALIMTA PR 500MG SUV Alt Item #: 3549623 NDC: 00002-7623-01 UPC: 300027-623016 Contract: Contract Alias: Strength: 500MG Form:

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
American Pharma Wholesale
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.